GSK Investigational Site is a clinical research site located in Princeton, New Jersey, United States 08540.
Crixeo Clinical Trials Trust Score: 18/100 (FAILING). This profile has not yet been claimed by the site owner.
GSK Investigational Site has participated in 9 clinical trials with 1 currently active.
Therapeutic areas: Bipolar Disorder, Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease.
Sponsors: GlaxoSmithKline, Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New Jersey · View every site in Princeton
Trust Score: 18/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
GSK Investigational Site has a Crixeo Trust Score of 18/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
GSK Investigational Site has 9 clinical trials on record, with 1 currently active. Their work covers Bipolar Disorder, Nonalcoholic Fatty Liver Disease, Non-alcoholic Fatty Liver Disease.
GSK Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.